Multimorbidity Risk Prediction for Schizophrenia (MRPS) is an open access comorbidity analysis tool developed for predicting the risk of morbidities in schizophrenia, based on shared gene-disease associations. This tool is based on the meta-analysis of 22 GWA studies and 654 SNPs (P Value < 5 × 10-8). The GWA studies had individuals with SCZ (and no other comorbidities) as case group and healthy individuals as control group. The ethnicity distribution of the 22 GWA studies included Asian (5), European (5), Ashkenazi Jews (1) and mix of east Asian, European and others (11). The gene-disease associations are sourced from GeDiPNet.
ClassAMP: Antimicrobial peptides (AMPs) are being explored as substitutes to antibiotics. The broad range of activity of AMPs, multiple cellular targets and their ability to inhibit multi-drug resistant microbes make them ideal candidates as future drugs. To explore AMPs as drugs it is essential to understand sequence-specificity relationship of AMPs. ClassAMP has been developed using Random Forests method to understand the role of sequence of AMPs in its specificity towards bacteria, fungii and viruses.